The Future of Facial Pain Research | The FPA Video Series
Vložit
- čas přidán 10. 10. 2023
- Although the video is not live, we encourage you to comment and ask questions. Your participation and feedback will help us gauge interest in a variety of topics to better serve the community with future webinars.
The FPA does not endorse any product, doctor, procedure, medical institution, or its staff.
The Facial Pain Association (FPA) is enthusiastic about medical research and encourages those with neuropathic facial pain, including trigeminal neuralgia, and related healthcare conditions to consider participation. It is important to note, however, that the FPA is not offering, nor is it qualified to offer, a scientific or medical endorsement of any Institutional Review Board (IRB) approved patient study. An IRB is a committee established to review and approve research involving human subjects. The purpose of the IRB is to ensure that all human subject research is conducted in accordance with all federal, institutional, and ethical guidelines. All studies and trials listed have IRB or Ethics Committee approval where relevant. The study’s safety and scientific validity is the sole responsibility of the study sponsors and investigators. Patients should use the contact information provided to contact the research organization for more information. Choosing to participate in a study is an important personal decision. Before you participate in a study, discuss all options with your healthcare provider. Although study sponsors may donate to the FPA, or support the FPA through advertising or corporate sponsorship, such support does not influence or guide our decision about the studies we identify.
Thank you for joining us for tonight's webinar! You can receive information and resources in your inbox when you sign up for FPA's Bulletin in this link www.facepain.org/sign-up/
Welcome to the FPA's Video Series featuring presentations from the 2023 FPA Conference. The topic for tonight’s webinar is The Future of Facial Pain Research with Raymond F. Sekula, Jr., MD, and Amine Tahiri, PharmD, MBA.
Dr. Sekula is the Director of the Trigeminal Neuralgia and Facial Pain Program and Professor of Neurological Surgery at The Neurological Institute at Columbia University and FPA Medical Advisory Board Chair. Amine Tahiri, PharmD, MBA, is the Vice President of Clinical Development for Adult Programs at Noema Pharma.
Although the video is not live, we encourage you to comment and ask questions. Your participation and feedback will help us gauge interest in a variety of topics to better serve the community with future webinars.
October is Facial Pain Awareness Month, an annual grassroots campaign to raise awareness about neuropathic facial pain. Learn more about how you can get involved by visiting www.facepain.org/face-today-together/
I have been diagnosed with a rare condition called infratrochlear neuralgia. Does anyone have this condition?
*The Facial Pain Association (FPA) is enthusiastic about medical research and encourages those with neuropathic facial pain, including trigeminal neuralgia, and related healthcare conditions to consider participation. It is important to note, however, that the FPA is not offering, nor is it qualified to offer, a scientific or medical endorsement of any Institutional Review Board (IRB) approved patient study. An IRB is a committee established to review and approve research involving human subjects. The purpose of the IRB is to ensure that all human subject research is conducted in accordance with all federal, institutional, and ethical guidelines. All studies and trials listed have IRB or Ethics Committee approval where relevant. The study’s safety and scientific validity is the sole responsibility of the study sponsors and investigators. Patients should use the contact information provided to contact the research organization for more information. Choosing to participate in a study is an important personal decision. Before you participate in a study, discuss all options with your healthcare provider. Although study sponsors may donate to the FPA, or support the FPA through advertising or corporate sponsorship, such support does not influence or guide our decision about the studies we identify.
I did my mvd surgery in Basel, Switzerland. Dr Raphael Guzman was my neurosurgeon. He listen to my symptoms agreed to do the surgery and did it successfully, I’m healing slowly from granulation tissue in my mouth from the surgery. I had glossopharyngeal neuralgia. Doctors in Sweden didn’t believed me.
Anyway I’m wondering if Dr Guzman have participate in figuring out this medication? Or who did in Basel?
What’s this medicine called?